InvestorsHub Logo
Followers 32
Posts 3544
Boards Moderated 0
Alias Born 07/02/2004

Re: joedebull post# 30459

Friday, 12/11/2009 8:38:22 PM

Friday, December 11, 2009 8:38:22 PM

Post# of 35633
That's a big call considering that there is one known lawsuit pending against CTGI from the La Jolla debacle....uh, debenture.

At 50 million OS, (more or less), the entire company including LTC and Carbon scrubbing, in theory, could be had for 12 million, more or less. Clearly DR won't accept that type of offer. He has a career's worth of time, aggravation and no small amount of $$ invested here.

IMO, there's no chance of CTGI bringing LTC to market alone. They lack the connections and the cash for such a massive rollout; hence a buyout of LTC is the best outcome for shareholders in the future. Also IMO, DR has done his dash with LTC- he found the technology and then he found the guy to get it through the FDA. I don't see any further rounds of FDA approvals, for organ suturing, etc, happening on DR's watch. All that remains is to make money from the technology. So what's the magic number that DR has in his mind for LTC? And how much compromise will it take for him to pull the trigger on a deal especially given the fact that he isn't as young a CEO as he was when this company started trying to convert farm waste to fuel 10+ years ago.

Hopefully with the lawsuits clearing up, a deal is imminent. Perhaps one of the conditions of a settlement for LTC is a clean rap sheet, ie, no outstanding legal actions against the company. On the other hand, if a deal was truly in the works and the $$ was substantial, why would CTGI issue shares instead of just paying off their legal debts with cash from all those proceeds?

PS: Unlike Greenblatt who DR took care of with his own shares, my reading of the Allison deal is that we're all diluted here by 2 million common shares.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.